Critical illness cover: the smart choice

In this series we have looked at group income protection (GIP) and group life assurance (GLA), and so in this third and final article we turn our attention to group critical illness (GCI). This is perhaps the most exciting product, as even in the last four years of indifferent market performance, the GCI product has had positive market growth and, in 2011, showed an impressive 9% increase in premiums. This growth has been encouraged by an alignment with flexible benefit schemes, perhaps illustrating its value to employees – after all most of us know someone who has had cancer or perha...